Fundraising FoxPangea Bio
6 known investors
Find your way into Pangea Bio
Sign up to find every way you can get introduced to Pangea Bio
- Your email: who you already know at Pangea Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Pangea Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Pangea Bio develops therapies targeting central nervous system and mental health disorders by activating the TrkB receptor pathway to promote neuronal survival and synaptic plasticity. The company serves patients with neurological and mental health conditions.
Investors · 6
Metaplanetlisted by MetaplanetTallinn · $500K – $10M
How we know: Metaplanet's portfolio page · the VCSheet dataset · Not right? Tell us
Palo Santo VClisted by Palo Santo VC
How we know: Palo Santo VC's portfolio page · Not right? Tell us
Seaside Ventureslisted by Seaside VenturesBoulder · $250K
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Pangea Bio do?
- Pangea Bio develops therapies targeting central nervous system and mental health disorders by activating the TrkB receptor pathway to promote neuronal survival and synaptic plasticity. The company serves patients with neurological and mental health conditions.
- Who are Pangea Bio's investors?
- Pangea Bio's investors include Metaplanet, NO LABEL VENTURES, Palo Santo VC, Seaside Ventures, Vox Capital, XEIA Venture Partners.